Bright Green Corporation (NASDAQ: BGXX) has disclosed its financial results for the third quarter ending September 30, 2023.
Under the leadership of executive chairman Terry Rafih, the company holds a position as one of the entities selected by the U.S. government to legally engage in the cultivation, manufacturing, and sale of cannabis and cannabis-related products for research and pharmaceutical purposes.
"Our registration by the U.S. Drug Enforcement Administration gives us the opportunity to advance our vision of improving quality of life through the opportunities presented by cannabis-derived therapies," according to the company.
Q3 2023 Financial Highlights
- The company reported no revenues for the third quarter, attributable to ongoing construction activities and regulatory procedures.
- Operating expenses for the quarter reduced to approximately $1.8 million, a decline from $5.8 million in Q3 2022, consistent with ...